Use existing data to analyze drug use behaviors, prevention strategies, and service utilization, aiming to advance substance use research.
Funder: National Institutes of Health
Due Dates: December 3, 2026 (Applications) | July 15, 2027 (Applications) | December 3, 2027 (Applications)
Funding Amounts: Budgets are not limited and must reflect project needs; up to 5 years
Summary: Supports innovative analyses of existing data to advance substance use, substance use disorder, and HIV prevention, treatment, and services research.
Key Information: Primary data collection and clinical trials are not allowed.
The National Institute on Drug Abuse (NIDA), part of NIH, supports R01 research projects that analyze existing social science, behavioral, administrative, and neuroimaging data. The program covers alcohol, tobacco, prescription drugs, and other substances, including their use trajectories, related disorders, morbidity and mortality, prevention, and health service utilization. It aims to make fuller use of public-use, community-based, and clinical datasets to answer novel research questions.
Priorities include risk and resilience, neurodevelopment, overdose prevention, policy effects, treatment and recovery, and the relationship between substance use and HIV. NIDA particularly encourages Adolescent Brain Cognitive Development (ABCD) Study analyses, harmonized datasets, innovative computational methods, and research with tangible implications for prevention, services, or policy. Qualitative analyses and integration of quantitative and qualitative data are also appropriate.